spironolactone and glp 1 PCOS Medications Fertility: A Comparison - Oana Chemical structures of aldosterone, spironolactone,
Description
For additional information on other multi-agonist approaches for treatment of complex diseases such as NASH, obesity and diabetes see Boettcher, B.R
however we cannot establish causality based on these retrospective results and further prospective investigations are needed. In the second study, researchers focused on examining how GLP-1 use might impact the risk of developing osteoporosis, gout, or osteomalacia (bone softening) in people with type 2 diabetes and obesity
investigation, H.A.L
We can't stress this enough: losing water is not the same as losing fat
